EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Dysfunction in Cardiovascular Diseases

Han-Mo Yang iD

International Journal of Molecular Sciences · 23.02.2025 · 26 (5) · 1917

DOI: 10.3390/ijms26051917 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.02.2025. Verfasst von Han-Mo Yang. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Mitochondria. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction is increasingly recognized as a central contributor to the pathogenesis of cardiovascular diseases (CVDs), including heart failure, ischemic heart disease, hypertension, and cardiomyopathy. Mitochondria, known as the powerhouses of the cell, play a vital role in maintaining cardiac energy homeostasis, regulating reactive oxygen species (ROS) production and controlling cell death pathways. Dysregulated mitochondrial function results in impaired adenosine triphosphate (ATP) production, excessive ROS generation, and activation of apoptotic and necrotic pathways, collectively driving the progression of CVDs. This review provides a detailed examination of the molecular mechanisms underlying mitochondrial dysfunction in CVDs, including mutations in mitochondrial DNA (mtDNA), defects in oxidative phosphorylation (OXPHOS), and alterations in mitochondrial dynamics (fusion, fission, and mitophagy). Additionally, the role of mitochondrial dysfunction in specific cardiovascular conditions is explored, highlighting its impact on endothelial dysfunction, myocardial remodeling, and arrhythmias. Emerging therapeutic strategies targeting mitochondrial dysfunction, such as mitochondrial antioxidants, metabolic modulators, and gene therapy, are also discussed. By synthesizing recent advances in mitochondrial biology and cardiovascular research, this review aims to enhance understanding of the role of mitochondria in CVDs and identify potential therapeutic targets to improve cardiovascular outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMitochondriaHumansAnimalsReactive Oxygen SpeciesDNA, MitochondrialMitochondrial DynamicsOxidative PhosphorylationMitophagy

Stichwörter der Autor:innen

cardiovascular diseasemitochondrial dynamicsmitochondrial dysfunctionoxidative stress

Substanzen

Reactive Oxygen SpeciesDNA, Mitochondrial

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.

ORCID-Profile: Han-Mo Yang

Förderung

  • National Research Foundation of Korea
  • Korean government

Zitieren

APA

Yang, H. M. (2025). Mitochondrial Dysfunction in Cardiovascular Diseases. International Journal of Molecular Sciences, 26(5), 1917. https://doi.org/10.3390/ijms26051917

Vancouver

Yang HM. Mitochondrial Dysfunction in Cardiovascular Diseases. International Journal of Molecular Sciences. 2025;26(5):1917. doi:10.3390/ijms26051917

BibTeX
@article{Yang2025,
  author = {Yang, Han-Mo},
  title = {Mitochondrial Dysfunction in Cardiovascular Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {1917},
  doi = {10.3390/ijms26051917}
}
Kostenlos starten →